Depression and congestive heart failure

Thomas P. Guck, Gary N. Elsasser, Michael G. Kavan, Eugene J. Barone

Research output: Contribution to journalReview article

71 Citations (Scopus)

Abstract

The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.

Original languageEnglish
Pages (from-to)163-169
Number of pages7
JournalCongestive Heart Failure
Volume9
Issue number3
StatePublished - May 2003

Fingerprint

Cognitive Therapy
Heart Failure
Depression
Serotonin Uptake Inhibitors
Patient Readmission
Tricyclic Antidepressive Agents
Self Report
Psychology
Physicians
Equipment and Supplies
Mortality
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Guck, T. P., Elsasser, G. N., Kavan, M. G., & Barone, E. J. (2003). Depression and congestive heart failure. Congestive Heart Failure, 9(3), 163-169.

Depression and congestive heart failure. / Guck, Thomas P.; Elsasser, Gary N.; Kavan, Michael G.; Barone, Eugene J.

In: Congestive Heart Failure, Vol. 9, No. 3, 05.2003, p. 163-169.

Research output: Contribution to journalReview article

Guck, TP, Elsasser, GN, Kavan, MG & Barone, EJ 2003, 'Depression and congestive heart failure', Congestive Heart Failure, vol. 9, no. 3, pp. 163-169.
Guck, Thomas P. ; Elsasser, Gary N. ; Kavan, Michael G. ; Barone, Eugene J. / Depression and congestive heart failure. In: Congestive Heart Failure. 2003 ; Vol. 9, No. 3. pp. 163-169.
@article{df3bbeaee52a4f7a9dc44579bcce1219,
title = "Depression and congestive heart failure",
abstract = "The prevalence rates of depression in congestive heart failure patients range from 24{\%}-42{\%}. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.",
author = "Guck, {Thomas P.} and Elsasser, {Gary N.} and Kavan, {Michael G.} and Barone, {Eugene J.}",
year = "2003",
month = "5",
language = "English",
volume = "9",
pages = "163--169",
journal = "Prevention and Management of Congestive Heart Failure",
issn = "1079-7998",
publisher = "Le Jacq Communications, Inc.",
number = "3",

}

TY - JOUR

T1 - Depression and congestive heart failure

AU - Guck, Thomas P.

AU - Elsasser, Gary N.

AU - Kavan, Michael G.

AU - Barone, Eugene J.

PY - 2003/5

Y1 - 2003/5

N2 - The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.

AB - The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.

UR - http://www.scopus.com/inward/record.url?scp=0042821891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042821891&partnerID=8YFLogxK

M3 - Review article

C2 - 12826775

AN - SCOPUS:0042821891

VL - 9

SP - 163

EP - 169

JO - Prevention and Management of Congestive Heart Failure

JF - Prevention and Management of Congestive Heart Failure

SN - 1079-7998

IS - 3

ER -